Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Leidos Selects Nuance Omnichannel Conversational AI Platform to Enhance Digital Patient Engagement Solutions for Healthcare Organizations

Nuance Communications (NUAN) announced that Leidos (LDOS), a Fortune 500® science and technology leader, will use Nuance’s AI technology as part of their scalable and customizable digital patient engagement solutions for health systems and federal healthcare agencies. Using the Nuance Mix™ conversational AI development platform, the same technology leveraged by the world’s leading banks, telecommunications companies, and retailers to create superior customer experiences, Leidos will help customers accelerate IT modernization, enhance patient experiences, and improve care costs and outcomes.

Recommended AI News: Singapore-Based Crypto Lending Platform Hodlnaut Partners with Leading Crypto Exchange Okcoin

“Our collaboration with Nuance adds important tools and flexibility to help build solutions that advance our customers’ missions to improve care quality, costs, and outcomes. The Nuance conversational AI platform and support team gives us the power to deploy enterprise-grade conversational AI and intelligent omnichannel development tools to design and deliver advanced, customized digital patient engagement solutions,” said Liz Porter, Leidos Health Group president.

“Healthcare providers are rapidly embracing modern omnichannel conversational AI technologies that improve experiences for patients and clinicians alike,” said Diana Nole, Executive Vice President and General Manager of Healthcare at Nuance. “With decades of experience modernizing enterprise IT infrastructures and solving difficult challenges, Leidos in collaboration with Nuance is poised to be a leader in helping healthcare organizations open their digital front doors with scalable patient engagement virtual assistant solutions.”

Related Posts
1 of 27,554

Recommended AI News: Microsoft Announces Quarterly Dividend Increase and New Share Repurchase Program

Alongside Nuance Mix, Nuance will provide a wide range of conversational AI technologies and technical design and advisory services to Leidos as it builds and delivers digital patient engagement solutions that complement existing provider systems. These solutions include appointment scheduling and reminder notifications, prescription reminders, side effects checking, and other use cases over multiple inbound and outbound voice and digital communications channels. This new collaboration builds on Leidos’ adoption of Nuance’s Dragon Medical One speech recognition solution to improve clinician workflow when performing evaluations.

Nuance Mix is part of Nuance’s portfolio of virtual assistant, patient and customer engagement, IVR, biometric security, and analytics solutions used by healthcare and other industry leaders worldwide including Providence St. Joseph, Walgreens, Albertsons, Best Buy, Humana, and Rakuten. Healthcare information technology leaders such as athenahealth, Cerner, Epic, and MEDITECH also use Nuance technology to power their provider-facing virtual assistant solutions.

Nuance Mix is an enterprise-grade cloud-based conversational AI development platform that extends the capabilities of Nuance’s Patient Engagement portfolio of solutions. It enables organizations to rapidly develop, test, deploy, and optimize virtual assistant, natural language, and speech solutions – reducing development and optimization time by more than 50 percent.

Recommended AI News: Boston Digital Bolsters Leadership Team

Comments are closed.